CVRS - Corindus Vascular Robotics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue10,7819,6502,8422,729
Cost of Revenue8,6739,2654,9543,724
Gross Profit2,108385-2,112-995
Operating Expenses
Research Development8,7699,51710,31310,033
Selling General and Administrative27,30024,77719,52716,143
Non Recurring----
Total Operating Expenses44,74243,55934,79429,900
Operating Income or Loss-33,961-33,909-31,952-27,171
Income from Continuing Operations
Total Other Income/Expenses Net-1,028-214-1,126-1,592
Earnings Before Interest and Taxes-33,961-33,909-31,952-27,171
Interest Expense-884-208-1,001-1,592
Income Before Tax-34,989-34,123-33,078-28,763
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-34,989-34,123-33,078-28,763
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-34,989-34,123-33,078-28,763
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-42,643-34,123-33,078-28,763